IPIAD augments standard therapy for pancreatic ductal adenocarcinoma

IPIAD augments standard therapy for pancreatic ductal adenocarcinoma
A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment o...
A new research perspective was published in Oncoscience (Volume 11) on February 7, 2024, entitled, "IPIAD- an augmentation regimen added to standard treatment o... Read More



Related Stories

See All